KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Astrana Health (ASTH) Non Operating Income (2016 - 2025)

Astrana Health (ASTH) has disclosed Non Operating Income for 16 consecutive years, with -$10.9 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 3184.7% to -$10.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$28.4 million through Dec 2025, down 4915.62% year-over-year, with the annual reading at -$38.9 million for FY2025, 898.34% down from the prior year.
  • Non Operating Income hit -$10.9 million in Q4 2025 for Astrana Health, up from -$13.5 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $61.6 million in Q2 2021 to a low of -$24.7 million in Q4 2021.
  • Historically, Non Operating Income has averaged -$476050.0 across 5 years, with a median of $426500.0 in 2021.
  • Biggest five-year swings in Non Operating Income: soared 500.92% in 2021 and later tumbled 3184.7% in 2025.
  • Year by year, Non Operating Income stood at -$24.7 million in 2021, then rose by 19.05% to -$20.0 million in 2022, then surged by 128.48% to $5.7 million in 2023, then tumbled by 93.8% to $353000.0 in 2024, then crashed by 3184.7% to -$10.9 million in 2025.
  • Business Quant data shows Non Operating Income for ASTH at -$10.9 million in Q4 2025, -$13.5 million in Q3 2025, and $1.1 million in Q2 2025.